StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) shareholders

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$144.46−3.30 (-2.23%)

Close on Nov 16, 2026Market cap $356.41BP/E 115.6Yield 2.27%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
80.3%
1.98B of 2.47B shares
Institutional holders
3,824
209 new, 116 sold out
Net institutional buying
56M
In Q2 2026
Insider trades, 12 months
0 buys · 34 sales
Net sold $79.29M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.201,836,4348.00%13G (passive) amendmentDec 31, 2023
Vanguard Capital Management186,323,7667.53%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MRKValueChange% of portfolio
BlackRock, Inc.226,999,8379.20%$29.17B+1,169,5070.43%
Vanguard Capital Management LLC161,323,1746.54%$20.73B+335,5500.44%
State Street Corp120,413,2564.88%$15.57B+1,087,5830.46%
Wellington Management Group Llp86,249,2833.50%$11.08B+1,934,3121.91%
Vanguard Portfolio Management LLC67,738,9692.75%$8.70B+434,6640.39%
Geode Capital Management, LLC60,744,2142.46%$7.79B+1,186,0600.42%
Charles Schwab Investment Management Inc54,365,2892.20%$6.99B+4,600,0640.93%
Morgan Stanley48,641,1581.97%$6.25B+1,008,6710.33%
FMR LLC45,440,3551.84%$5.84B+924,3450.25%
JPMorgan Chase & Co43,886,4201.78%$5.68B−9,086,5630.31%
Fisher Asset Management, LLC38,516,2631.56%$4.95B+12,079,9791.47%
Norges Bank36,983,7841.50%$4.75BNew0.47%
Bank Of America Corp /De/30,535,2081.24%$3.92B−239,0130.25%
Northern Trust Corp26,275,7181.07%$3.38B−814,3050.39%
Goldman Sachs Group Inc22,075,1390.89%$2.84B+1,941,7600.25%
Franklin Resources Inc19,548,5850.79%$2.51B+3,281,3800.54%
UBS Asset Management Americas Inc19,547,1710.79%$2.51B−867,6480.46%
Legal & General Group Plc18,873,3430.76%$2.43B−665,2020.51%
Invesco Ltd.18,611,1710.75%$2.39B−3,243,9300.19%
Price T Rowe Associates Inc /Md/18,518,7960.75%$2.38B−4,524,0460.24%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20263,8241.98B80.3%209 / 16321492 / 116135M80M
Q1 20263,7961.93B78.3%317 / 14611587 / 123361M144M
Q4 20253,6581.97B80.0%549 / 13771402 / 130181M144M
Q3 20253,3101.94B78.7%192 / 13641420 / 149112M152M
Q2 20253,3251.98B80.4%179 / 12991533 / 253122M114M
Q1 20253,4471.98B80.3%183 / 13471596 / 275150M134M
Q4 20243,6011.99B80.5%390 / 13211574 / 208153M135M
Q3 20243,4851.99B80.5%148 / 15251419 / 161304M93M
Q2 20243,5391.98B80.4%177 / 16071362 / 11983M148M
Q1 20243,5322.06B83.4%260 / 14121487 / 112146M83M
Q4 20233,4292.01B81.3%380 / 12451482 / 107156M64M
Q3 20233,2091.92B77.9%148 / 12961405 / 14863M76M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

1,428 funds held MRK in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of MRKValue% of fundAs of
Vanguard Total Stock Market Index Fund78,411,3743.18%$10.08B0.44%Jun 30, 2026
Vanguard 500 Index Fund63,996,8842.59%$8.22B0.49%Jun 30, 2026
iShares Core S&P 500 ETF33,973,7431.38%$4.37B0.49%Jun 30, 2026
Fidelity 500 Index Fund31,762,5031.29%$3.77B0.45%May 31, 2026
Schwab U.S. Dividend Equity ETF30,860,8331.25%$3.66B3.86%May 31, 2026
Vanguard Value Index Fund23,507,7030.95%$3.02B1.19%Jun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF17,448,5770.71%$2.24B5.52%Jun 30, 2026
Vanguard Health Care Fund15,950,8340.65%$2.08B5.44%Jul 31, 2026
Vanguard Dividend Appreciation Index Fund13,974,1480.57%$1.82B1.39%Jul 31, 2026
Vanguard Institutional Index Fund13,407,8640.54%$1.72B0.49%Jun 30, 2026
Vanguard Equity Income Fund12,367,5410.50%$1.59B2.43%Jun 30, 2026
Vanguard High Dividend Yield Index Fund9,961,1160.40%$1.30B1.31%Jul 31, 2026
Vanguard Wellington Fund9,932,2680.40%$1.18B0.95%May 31, 2026
Washington Mutual Investors Fund8,487,0460.34%$1.11B0.51%Jul 31, 2026
Vanguard Health Care Index Fund7,454,5490.30%$885.00M4.66%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Robert M. DavisChairman, CEO & President, Director450,3510.02%May 7, 2026
Richard R. DeLucaEVP&Pres, Merck Animal Heallth114,2910.00%Nov 16, 2026
David R. MaraldoEVP & Pres. MMD23,7690.00%Oct 22, 2026
Gaurav K. GuptaEVP, CIDO7500.00%Sep 1, 2026
Chirfi GuindoEVP, Access, Policy & Comms36,6700.00%Aug 13, 2026
Jennifer ZacharyEVP, General Counsel125,8240.01%Aug 13, 2026
David Michael WilliamsEVP,Chief Info&Digital Officer31,7160.00%Aug 7, 2026
Dalton E. Smart IIISVP Fin. - Global Controller9,3880.00%May 7, 2026
Betty D. LarsonEVP, Chief HR Officer13,7740.00%May 7, 2026
Johannes Jacobus OosthuizenEVP, Oncology & Int?l21,8950.00%May 7, 2026
Brian FoardEVP, Specialty, Pharma, & ID––May 7, 2026
Caroline LitchfieldEVP & CFO92,3010.00%May 7, 2026
Dean Y. LiExecutive VP & President, MRL94,4310.00%May 7, 2026
Sanat ChattopadhyayExe V-P & Pres. MMD200,6750.01%May 1, 2026
Joseph RomanelliPresident, Human Health Int?l28,7390.00%Jan 28, 2026
Cristal N. DowningChief Comm. & Public Afrs Ofcr0–Nov 12, 2025
Paul J. DiazDirector2960.00%Nov 3, 2026
Christine E. SeidmanDirector1000.00%Oct 1, 2026
Mary Ellen CoeDirector100.00%Oct 1, 2026
Surendralal Lanca KarsanbhaiDirector10.00%Oct 1, 2026
Paul RothmanDirector1000.00%Jun 2, 2026
Risa J. Lavizzo-MoureyDirector1,0000.00%Jun 2, 2026
Stephen MayoDirector1000.00%Jun 2, 2026
Patricia F. RussoDirector13,1480.00%Jun 2, 2026
Douglas M. Baker JrDirector16,0000.00%Jun 2, 2026
Kathy J. WardenDirector5000.00%Jun 2, 2026
Inge G. ThulinDirector2,9330.00%Jun 2, 2026
Pamela J. CraigDirector1,7150.00%Jun 2, 2026
Thomas H. GlocerDirector5,1000.00%Jun 2, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Nov 12, 2026Sale−58,185$148.01$8.61M112,955
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Nov 12, 2026Option exercise+58,185$77.62$4.52M171,140
Chirfi Guindo
EVP, Access, Policy & Comms
Aug 13, 2026Sale−10,000$135.00$1.35M36,613
Jennifer Zachary
EVP, General Counsel
Aug 12, 2026Option exercise+13,433$84.71$1.14M125,824
Jennifer Zachary
EVP, General Counsel
Aug 12, 2026Sale−80,315$133.46$10.72M45,509
Jennifer Zachary
EVP, General Counsel
Aug 12, 2026Option exercise+41,494$117.89$4.89M112,391
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Aug 12, 2026Sale−600$132.04$79.22K110,167
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Aug 12, 2026Sale−11,099$131.61$1.46M110,767
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Aug 11, 2026Sale−5,427$132.35$718.26K121,866
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Aug 11, 2026Sale−7,410$131.33$973.16K127,293
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Aug 10, 2026Sale−20,784$130.43$2.71M134,703
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Aug 6, 2026Sale−4,945$130.23$643.99K155,787
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Aug 6, 2026Sale−300$131.02$39.31K155,487
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Aug 6, 2026Sale−805$131.02$105.47K160,732
Chirfi Guindo
EVP, Access, Policy & Comms
Aug 6, 2026Sale−15,000$131.00$1.97M46,613
David R. Maraldo
EVP & Pres. MMD
Aug 5, 2026Option exercise+2,686$84.71$227.53K20,898
David R. Maraldo
EVP & Pres. MMD
Aug 5, 2026Option exercise+6,311$73.73$465.31K24,523
David R. Maraldo
EVP & Pres. MMD
Aug 5, 2026Sale−6,311$128.72$812.35K18,212
David R. Maraldo
EVP & Pres. MMD
Aug 5, 2026Sale−2,686$128.72$345.74K18,212
David R. Maraldo
EVP & Pres. MMD
Aug 5, 2026Sale−9,709$128.72$1.25M18,212
David R. Maraldo
EVP & Pres. MMD
Aug 5, 2026Option exercise+9,709$87.10$845.65K27,921
David Michael Williams
EVP,Chief Info&Digital Officer
Aug 5, 2026Sale−13,542$128.77$1.74M31,716
David Michael Williams
EVP,Chief Info&Digital Officer
Aug 5, 2026Option exercise+4,600$77.62$357.05K36,316
David Michael Williams
EVP,Chief Info&Digital Officer
Aug 5, 2026Sale−4,600$128.77$592.34K31,716
David Michael Williams
EVP,Chief Info&Digital Officer
Aug 5, 2026Option exercise+13,542$75.36$1.02M45,258
David Michael Williams
EVP,Chief Info&Digital Officer
Aug 5, 2026Sale−34,705$128.77$4.47M31,716
David Michael Williams
EVP,Chief Info&Digital Officer
Aug 5, 2026Option exercise+34,705$73.73$2.56M66,421
Dalton E. Smart III
SVP Fin. - Global Controller
May 2, 2026Tax withholding−132$112.16$14.81K9,388
Dalton E. Smart III
SVP Fin. - Global Controller
May 2, 2026Option exercise+383$112.16$42.96K9,520
David R. Maraldo
EVP & Pres. MMD
May 2, 2026Option exercise+552$112.16$61.91K18,371
David R. Maraldo
EVP & Pres. MMD
May 2, 2026Tax withholding−159$112.16$17.83K18,212
Betty D. Larson
EVP, Chief HR Officer
Apr 30, 2026Tax withholding−5,143$110.95$570.62K13,774
Betty D. Larson
EVP, Chief HR Officer
Apr 30, 2026Option exercise+11,350$110.95$1.26M18,917
Dalton E. Smart III
SVP Fin. - Global Controller
Apr 30, 2026Option exercise+464$110.95$51.48K9,296
Dalton E. Smart III
SVP Fin. - Global Controller
Apr 30, 2026Tax withholding−159$110.95$17.64K9,137
Johannes Jacobus Oosthuizen
EVP, Oncology & Int?l
Apr 29, 2026Option exercise+1,377$110.03$151.51K22,574
Johannes Jacobus Oosthuizen
EVP, Oncology & Int?l
Apr 29, 2026Tax withholding−679$110.03$74.71K21,895
Caroline Litchfield
EVP & CFO
Apr 29, 2026Option exercise+3,935$110.03$432.97K94,239
Caroline Litchfield
EVP & CFO
Apr 29, 2026Tax withholding−1,938$110.03$213.24K92,301
Betty D. Larson
EVP, Chief HR Officer
Apr 29, 2026Option exercise+2,085$110.03$229.41K8,282
Betty D. Larson
EVP, Chief HR Officer
Apr 29, 2026Tax withholding−715$110.03$78.67K7,567
Jennifer Zachary
EVP, General Counsel
Apr 29, 2026Option exercise+2,951$110.03$324.70K72,351
Jennifer Zachary
EVP, General Counsel
Apr 29, 2026Tax withholding−1,454$110.03$159.98K70,897
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Apr 29, 2026Tax withholding−1,241$110.03$136.55K161,537
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Apr 29, 2026Option exercise+2,518$110.03$277.06K162,778
Chirfi Guindo
EVP, Access, Policy & Comms
Apr 29, 2026Option exercise+1,967$110.03$216.43K62,582
Chirfi Guindo
EVP, Access, Policy & Comms
Apr 29, 2026Tax withholding−969$110.03$106.62K61,613
David Michael Williams
EVP,Chief Info&Digital Officer
Apr 29, 2026Option exercise+1,377$110.03$151.51K32,395
David Michael Williams
EVP,Chief Info&Digital Officer
Apr 29, 2026Tax withholding−679$110.03$74.71K31,716
Sanat Chattopadhyay
Exe V-P & Pres. MMD
Apr 29, 2026Tax withholding−1,130$110.03$124.33K15,347
Sanat Chattopadhyay
Exe V-P & Pres. MMD
Apr 29, 2026Option exercise+2,597$110.03$285.75K16,477
Dalton E. Smart III
SVP Fin. - Global Controller
Apr 29, 2026Option exercise+944$110.03$103.87K9,156
Dalton E. Smart III
SVP Fin. - Global Controller
Apr 29, 2026Tax withholding−324$110.03$35.65K8,832
Robert M. Davis
Chairman, CEO & President, Director
Apr 29, 2026Option exercise+13,300$110.03$1.46M456,902
Robert M. Davis
Chairman, CEO & President, Director
Apr 29, 2026Tax withholding−6,551$110.03$720.81K450,351
Dean Y. Li
Executive VP & President, MRL
Apr 29, 2026Tax withholding−2,326$110.03$255.93K94,431
Dean Y. Li
Executive VP & President, MRL
Apr 29, 2026Option exercise+4,722$110.03$519.56K96,757
Chirfi Guindo
Chief Marketing Officer
Feb 12, 2026Sale−10,000$121.46$1.21M60,615
Dean Y. Li
Executive VP & President, MRL
Feb 10, 2026Sale−10,235$117.52$1.20M92,035
Chirfi Guindo
Chief Marketing Officer
Feb 9, 2026Sale−10,000$118.41$1.18M70,615

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
1.08%
27M shares short
Days to cover
2.4
At 11M shares a day
Change since last report
-0.8%
From 27M shares
Short volume, 20 days
38.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Merck's stock actually held short. Settlement fails (shares not delivered on time) peaked at 69,948 shares on Oct 9, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
David Michael Williams
Officer
Nov 2, 202621,359$3.19MNov 2, 2026Exercise of Options Under a Registered Plan
Chirfi Guindo
Officer
Aug 13, 202610,000$1.35MAug 13, 2026Restricted Stock Vesting Under a Registered Plan
Jennifer Zachary
Officer
Aug 12, 202680,315$10.72MAug 12, 2026Exercise of Options Under a Registered Plan
Richard Robert Deluca Jr
Officer
Aug 12, 202611,699$1.54MAug 12, 2026Restricted Stock Vesting Under a Registered Plan
Richard Robert Deluca Jr
Officer
Aug 11, 202612,837$1.69MAug 11, 2026Restricted Stock Vesting Under a Registered Plan
Richard Robert Deluca Jr
Officer
Aug 10, 202620,784$2.71MAug 10, 2026Restricted Stock Vesting Under a Registered Plan
Chirfi Guindo
Officer
Aug 6, 202615,000$1.97MAug 6, 2026Restricted Stock Vesting Under a Registered Plan
Richard Robert Deluca Jr
Officer
Aug 6, 20266,050$788.77KAug 6, 2026Restricted Stock Vesting Under a Registered Plan
David Michael Williams
Officer
Aug 5, 202652,847$6.81MAug 5, 2026Exercise of Options Under a Registered Plan
David R. Maraldo
Officer
Aug 5, 202618,706$2.41MAug 5, 2026Exercise of Options Under a Registered Plan
Chirfi Guindo
Officer
Feb 13, 202620,000$2.37MFeb 9, 2026Restricted stock vesting under a registered plan
Dean Y. Li
Officer
Feb 10, 202610,235$1.20MFeb 10, 2026Restricted stock vesting under a registered plan
Jennifer Zachary
Officer
Feb 9, 2026121,573$14.49MFeb 9, 2026Exercise of options under a registered plan
Chirfi Guindo
Officer
Feb 9, 202620,000$2.37MFeb 9, 2026Restricted stock vesting under a registered plan
Richard Robert Deluca Jr.
Officer
Feb 6, 202637,685$4.56MFeb 6, 2026Restricted stock vesting under a registered plan

Congress trades

40 trades in Merck reported by 17 members of the House

MemberTypeTradedAmountFiled
Maria Elvira Salazar
FL27
Sold (part)Sep 24, 2026$1K–15KOct 7, 2026
Michael T. McCaul
TX10 · spouse
SoldAug 28, 2026$50K–100KOct 14, 2026
47 days late
Maria Elvira Salazar
FL27
BoughtAug 19, 2026$15K–50KSep 9, 2026
Maria Elvira Salazar
FL27
BoughtAug 19, 2026$15K–50KSep 9, 2026
Josh Gottheimer
NJ05 · joint account
BoughtFeb 4, 2026$1K–15KMar 16, 2026
Michael T. McCaul
TX10 · spouse
SoldJan 13, 2026$15K–50KFeb 11, 2026
Gilbert Cisneros
CA31
BoughtDec 19, 2025$1K–15KJan 12, 2026
Julie Johnson
TX32 · joint account
SoldDec 18, 2025$1K–15KJan 15, 2026
Gilbert Cisneros
CA31
BoughtNov 18, 2025$1K–15KDec 15, 2025
Julie Johnson
TX32 · joint account
Sold (part)Nov 13, 2025$1K–15KDec 11, 2025
Valerie Hoyle
OR04 · spouse
SoldSep 23, 2025$1K–15KOct 10, 2025
Marjorie Taylor Greene
GA14
BoughtAug 28, 2025$1K–15KAug 29, 2025
Julie Johnson
TX32 · joint account
Sold (part)Aug 14, 2025$1K–15KSep 11, 2025
Gilbert Cisneros
CA31
BoughtAug 5, 2025$1K–15KSep 12, 2025
Lisa McClain
MI09 · spouse
SoldAug 4, 2025$1K–15KSep 12, 2025
Ritchie John Torres
NY15
SoldJul 11, 2025$1K–15KAug 20, 2025
Lisa McClain
MI09 · spouse
BoughtJun 24, 2025$1K–15KAug 13, 2025
50 days late
Scott Scott Franklin
FL18 · joint account
SoldJun 16, 2025$1K–15KJul 14, 2025
Julie Johnson
TX32 · joint account
BoughtJun 13, 2025$1K–15KJul 14, 2025
Gilbert Cisneros
CA31
SoldMay 30, 2025$1K–15KJun 6, 2025
Rob Bresnahan
PA08
SoldMay 15, 2025$15K–50KMay 31, 2025
Marjorie Taylor Greene
GA14
BoughtMay 5, 2025$1K–15KMay 6, 2025
Gilbert Cisneros
CA31
BoughtApr 29, 2025$1K–15KMay 6, 2025
Bruce Westerman
AR04
SoldApr 21, 2025$1K–15KMay 12, 2025
Jefferson Shreve
IN06
SoldApr 17, 2025$15K–50KMay 8, 2025
Marjorie Taylor Greene
GA14
BoughtApr 9, 2025$1K–15KApr 11, 2025
Rob Bresnahan
PA08
BoughtApr 8, 2025$15K–50KMay 8, 2025
Gilbert Cisneros
CA31
Sold (part)Mar 31, 2025$15K–50KApr 7, 2025
Kelly Louise Morrison
MN03
Sold (part)Mar 20, 2025$1K–15KApr 11, 2025
Sheri Biggs
SC03 · spouse
SoldMar 19, 2025$15K–50KOct 5, 2025
200 days late
Bruce Westerman
AR04
BoughtMar 3, 2025$1K–15KApr 16, 2025
Gilbert Cisneros
CA31
BoughtFeb 26, 2025$15K–50KMar 6, 2025
Rob Bresnahan
PA08
SoldFeb 25, 2025$15K–50KMar 27, 2025
Jefferson Shreve
IN06
BoughtFeb 24, 2025$15K–50KMar 9, 2025
Josh Gottheimer
NJ05 · joint account
SoldJan 27, 2025$15K–50KFeb 10, 2025
Gilbert Cisneros
CA31
SoldJan 24, 2025$1K–15KFeb 11, 2025
Julie Johnson
TX32 · joint account
BoughtJan 17, 2025$1K–15KFeb 12, 2025
Byron Donalds
FL19 · spouse
SoldJan 16, 2025$1K–15KFeb 10, 2025
Byron Donalds
FL19
SoldJan 16, 2025$1K–15KFeb 10, 2025
Jared Moskowitz
FL23 · child
SoldJan 15, 2025$1K–15KFeb 10, 2025

See a number that looks wrong?